Nonrapid eye movement sleep and risk for autism spectrum disorder in early development: A topographical

Jessica Page1,2,3, Caroline Lustenberger1,4, Flavio Frӧhlich1,2,5,6,7,8

  • 1Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Brain and Behavior
|February 11, 2020
PubMed

Insights

Early diagnosis of autism spectrum disorder (ASD) is crucial. This study found distinct nonrapid eye movement (NREM) sleep EEG patterns in toddlers with ASD, suggesting NREM sleep may be an early biomarker for autism.

Area of Science:

  • Neurodevelopmental disorders
  • Pediatric sleep medicine
  • Brain imaging and electrophysiology

Background:

  • Autism spectrum disorder (ASD) is a neurodevelopmental disorder diagnosed in early childhood.
  • Early diagnosis of ASD is challenging, often delaying crucial interventions.
  • Identifying early brain markers, such as through electroencephalogram (EEG), is critical for timely intervention.

Purpose of the Study:

  • To investigate nonrapid eye movement (NREM) sleep EEG spectral features in infants and toddlers with or at high risk for ASD.
  • To explore NREM sleep as a potential early diagnostic marker for ASD during a critical developmental period.

Main Methods:

  • A pilot study comparing NREM sleep EEG in 13- to 30-month-olds with ASD and age-matched typically developing (TD) controls.
  • High-density array EEG was recorded during daytime naps.

Main Results:

  • Infants and toddlers with ASD exhibited distinct NREM sleep EEG patterns compared to TD controls.
  • Specifically, decreased fast theta and sigma oscillations, alongside increased beta oscillations, were observed in the ASD group.

Conclusions:

  • NREM sleep spectral features show developmental trajectories that may be altered in ASD.
  • These findings support the potential of NREM sleep EEG as an early biomarker for autism spectrum disorder.
Abstract

Related Concept Videos